JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

HER2

HER2 is a member of the epidermal growth factor. It initiates the EGF downstream cascade by forming a heterodimer with other ligand-bound EGF receptor. It is associated with breast and ovarian cancers.

A4092 CUDC-101
1 Citation

Target: Histone Deacetylases (HDACs)|EGFR|ErbB

Summary: Multitargeted HDAC inhibitor

≥21.7 mg/mL
A3145 Afatinib dimaleate

Target: EGFR|HER2

Summary: EGFR inhibitor

≥35.9 mg/mL
A3252 BMS-599626 Hydrochloride

Summary: EGFR/HER2 inhibitor,potent and selective

≥29.05 mg/mL
A3276 Canertinib dihydrochloride

Summary: Pan-ErbB inhibitor, potent and selective

≥21.8 mg/mL